Grotto, Rejane Maria Tommasini [UNESP]Santos Lima, Rodrigo [UNESP]de Almeida, Gabriel Berg [UNESP]Ferreira, Claudia Pio [UNESP]Guimarães, Raul Borges [UNESP]Pronunciate, Micheli [UNESP]Azevedo, Edmur [UNESP]Catão, Rafael de CastroFortaleza, Carlos Magno Castelo Branco [UNESP]2020-12-122020-12-122020-08-18Epidemiology and infection, v. 148, p. e178-.1469-4409http://hdl.handle.net/11449/202081Different countries have adopted strategies for the early detection of SARS-CoV-2 since the declaration of community transmission by the World Health Organization (WHO) and timely diagnosis has been considered one of the major obstacles for surveillance and healthcare. Here, we report the increase of the number of laboratories to COVID-19 diagnosis in Brazil. Our results demonstrate an increase and decentralisation of certified laboratories, which does not match the much higher increase in the number of COVID-19 cases. Also, it becomes clear that laboratories are irregularly distributed over the country, with a concentration in the most developed state, São Paulo.e178engCOVID-19diagnosisepidemiologyinfectious diseaselaboratory testsIncreasing molecular diagnostic capacity and COVID-19 incidence in BrazilArtigo10.1017/S09502688200018182-s2.0-85090507402802252746836945920527496982046170000-0002-9925-53740000-0002-9404-6098